DNLI
Denali Therapeutics Inc. · Healthcare · Market cap $3.0B
Insiders sold $435K net in the last 90 days ·3 sellers, 0 buyers· 2 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 9, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 9, 2026
Chin Peter Scott
Denali Therapeutics Inc. (DNLI) has 18 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 9, 2026.
Inside the rolling window, 4 insiders at Denali Therapeutics Inc. reported no open-market purchases and 6 open-market sales totaling $1.3M. The most active filer is COFO and Secretary Schuth Alexander O. with 3 filings. Insiders have net sold $435K over the trailing 6 months. The most recent open-market filing is a sale of 1,654 shares by Chief Medical Officer Chin Peter Scott, dated Sep 4, 2026, worth $37K.
- Industry:Biotechnology
- CEO:Ryan J. Watts
- Employees:503
- HQ:South San Francisco, CA, US
- IPO:2017-12-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
Chin Peter ScottFirst filing | Chief Medical Officer | Sale | 1,654 | $37K | Sep 9 | -13.4% | SEC ↗ |
Thornberry NancyFirst filing | Director | Sale | 11,439 | $262K | Sep 4 | -16.2% | SEC ↗ |
| COFO and Secretary | Sale | 2,768 | $65K | Sep 3 | -18.1% | SEC ↗ | |
Schuth Alexander O.First in 7 months | COFO and Secretary | Sale | 2,857 | $72K | Aug 13 | -24.7% | SEC ↗ |
Schuth Alexander O.First filing | COFO and Secretary | Sale | 17,218 | $284K | Jan 8 | +9.4% | SEC ↗ |
Watts Ryan J.First filing | President and CEO | Sale | 35,198 | $581K | Jan 8 | +9.4% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does DNLI have?
Denali Therapeutics Inc. (DNLI) has 18 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 9, 2026.
When was the most recent SEC Form 4 filing for DNLI?
The most recent Form 4 filing for DNLI on Tracefour is dated Sep 9, 2026.
Who is the most active insider at DNLI?
The most active SEC Form 4 filer at DNLI in the rolling window is COFO and Secretary Schuth Alexander O., with 3 filings.
What is the net insider flow at DNLI over the last 6 months?
Over the trailing 180 days, insiders at DNLI have net sold $435K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at DNLI in the current window?
Inside the rolling window, insiders at DNLI bought $0 and sold $1.3M based on SEC Form 4 filings.
Can I get alerts for DNLI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Denali Therapeutics Inc. (DNLI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Denali Therapeutics Inc. is in the Healthcare sector.